Lighting systems, methods, and devices for protecting human circadian neuroendocrine function during night use are described. Suitable lighting conditions can be provided for a working environment while protecting the circadian neuroendocrine systems of those occupying the illuminated workplace during the night. Lighting systems, methods, and devices can provide substantive attenuation of the pathologic circadian disruption in night workers. Lighting systems, methods, and devices can attenuate the specific bands of light implicated in circadian disruption. LED lighting systems, methods, and devices can provide increased intensity at a different portion of the spectrum than conventional LEDs, providing a useable white light even when unfavorable portions of the wavelength are attenuated by a notch filter. LED lighting systems, methods, and devices can switch between a daytime configuration and a night time configuration, wherein the daytime configuration provides unfiltered light and the night time configuration provides filtered light.

Systems and associated methods are provided for monitoring a user while operating a computing device and providing active feedback to said user regarding health and safety best practices associated with operating said computing device. The methods comprise obtaining user biometric data; converting said biometric data into actionable instances of health and safety user device operation use cases; and interacting with the user based on said actionable instances in order to improve or remedy any deviations from recommended health and safety user device operation practices.

Systems and associated methods are provided for monitoring a user while operating a computing device and providing active feedback to said user regarding health and safety best practices associated with operating said computing device. The methods comprise obtaining user biometric data; converting said biometric data into actionable instances of health and safety user device operation use cases; and interacting with the user based on said actionable instances in order to improve or remedy any deviations from recommended health and safety user device operation practices.

Systems and methods are provided to combine multiple stimulation modalities to significantly increase the effectiveness of non-invasive stimulation. Multiple sensor and stimulation devices and modalities can be combined into a single, compact unit that minimizes the need for additional sensors or stimulation devices. The system features several subunits, referred to as sensory and stimulation devices (SSD), that are integrated into a headphone setup. The system is controlled by a centralized controller that communicates with all of the SSDs and with an external computer system that delivers learning material synchronized with the delivery of stimulations and the collection of user responses based on physiological signals.

Systems and methods are provided to combine multiple stimulation modalities to significantly increase the effectiveness of non-invasive stimulation. Multiple sensor and stimulation devices and modalities can be combined into a single, compact unit that minimizes the need for additional sensors or stimulation devices. The system features several subunits, referred to as sensory and stimulation devices (SSD), that are integrated into a headphone setup. The system is controlled by a centralized controller that communicates with all of the SSDs and with an external computer system that delivers learning material synchronized with the delivery of stimulations and the collection of user responses based on physiological signals.

An anti-motion sickness device fitted to a motor vehicle including a triaxial accelerometer to detect the vehicle accelerations along three axes and to emit a corresponding acceleration signal; a display component of light markers to form at least one first and second artificial horizon lines at first and second inner surface, respectively of the motor vehicle. The device includes a control unit for receiving the acceleration signals and for driving the display wherein the artificial horizon lines are aligned in a horizontal plane perpendicular or substantially perpendicular to the gravity vector regardless of vehicle accelerations. The control unit is configured to process the acceleration signals, prior to the control of the display to determine in real time an acceleration frequency according to each of the accelerometer axes and to drive the display only when the acceleration frequency is below a threshold frequency, below which the motion sickness likely occurs.

An anti-motion sickness device fitted to a motor vehicle including a triaxial accelerometer to detect the vehicle accelerations along three axes and to emit a corresponding acceleration signal; a display component of light markers to form at least one first and second artificial horizon lines at first and second inner surface, respectively of the motor vehicle. The device includes a control unit for receiving the acceleration signals and for driving the display wherein the artificial horizon lines are aligned in a horizontal plane perpendicular or substantially perpendicular to the gravity vector regardless of vehicle accelerations. The control unit is configured to process the acceleration signals, prior to the control of the display to determine in real time an acceleration frequency according to each of the accelerometer axes and to drive the display only when the acceleration frequency is below a threshold frequency, below which the motion sickness likely occurs.

Systems and methods are provided for identifying a therapeutic VR activity or exercise for a subject/patient based on the subject's impairments, dynamically adjusting a VR activity for a patient, and identifying potential impairments based on a patient's performance in a VR activity. Patients may each have various physical, neurological, cognitive, and/or sensory impairments to be treated. Not all therapeutic activities may be appropriate for some patients and their impairments. A VR therapeutic activity platform may increase patient engagement and challenge patients at more appropriate times by better matching activities corresponding to a patient's impairments and dynamically adjusting each VR activity based on performance to offer a challenging and rewarding therapeutic experience.

An on-person portable device and/or app that allows for constant location monitoring of dementia patients is disclosed. Such a device and/or app also includes automated communication of facial recognition of persons proximally near such a patient as well as possible generation of certain music in response to patient status and/or location. The patient is provided the device and/or app for handling or wearing, such as a phone or pair of glasses, in order to follow location through GPS monitoring, and a reactive program therein that automatically views another person and provides an identification thereof coupled with a voice modulator within an earpiece or like device for memory stimulation pertaining to loved ones or friends, and the like. The same program may also provide the music response to comments, movement, or any other external stimuli to the subject patient, again, to evoke a memory stimulus, as well.

A method for treating conditions associated with thalamocortical dysrhythmia. The method includes applying transcranial low voltage electrical stimulation (TLVES) therapy or transcranial magnetic stimulation (TMS) therapy to a patient in need thereof, and administering to the patient a dissociative anesthetic during the TLVES therapy or the TMS therapy. A number of conditions including tinnitus, depression and pain can be treated with TLVES or TMS in combination with the dissociative anesthetic, such as an NMADR inhibitor, including ketamine.